Aura Biosciences (AURA) Free Cash Flow (2020 - 2026)
Aura Biosciences (AURA) posted Free Cash Flow of -$29.9 million for Q1 2026, down 45.31% on a QoQ basis from -$20.6 million in Q4 2025, and down 28.19% year-over-year from -$41.7 million in Q1 2025.
Aura Biosciences (AURA) Free Cash Flow (2020 - 2026) Analysis & Trends
Aura Biosciences' Free Cash Flow history runs 7 years deep, the most recent figure standing at -$29.9 million for Q1 2026.
- Quarterly Free Cash Flow fell 28.19% year-over-year to -$29.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$91.7 million (down 14.89% YoY) and the FY2025 annual result came in at -$85.1 million, down 5.04% from the prior year.
- Free Cash Flow was -$29.9 million for Q1 2026 at Aura Biosciences, down from -$20.6 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$10.7 million in Q2 2022 and bottomed at -$29.9 million in Q1 2026.
- A 5-year average of -$18.5 million and a median of -$17.2 million in 2023 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2022 — Free Cash Flow plunged 197.83% — and 2025, when it gained 19.8%.
- Aura Biosciences' Free Cash Flow stood at -$17.5 million in 2022, then rose by 1.36% to -$17.2 million in 2023, then plunged by 49.2% to -$25.7 million in 2024, then gained by 19.8% to -$20.6 million in 2025, then slumped by 45.31% to -$29.9 million in 2026.
- Business Quant data shows AURA's Free Cash Flow at -$29.9 million in Q1 2026, -$20.6 million in Q4 2025, and -$20.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Aura Biosciences | 485.62 Mn | 400.83 Mn | - | -29.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.94 Mn |
| Mar 31, 2026 | -29.94 Mn |
| Dec 31, 2025 | -20.60 Mn |
| Dec 31, 2025 | -20.60 Mn |
| Sep 30, 2025 | -20.19 Mn |
| Sep 30, 2025 | -20.19 Mn |
| Jun 30, 2025 | -21.00 Mn |
| Jun 30, 2025 | -21.00 Mn |
| Mar 31, 2025 | -23.36 Mn |
| Mar 31, 2025 | -23.36 Mn |
| Dec 31, 2024 | -25.69 Mn |
| Dec 31, 2024 | -25.69 Mn |
| Sep 30, 2024 | -14.85 Mn |
| Sep 30, 2024 | -14.85 Mn |
| Jun 30, 2024 | -15.94 Mn |
| Jun 30, 2024 | -15.94 Mn |
| Mar 31, 2024 | -24.57 Mn |
| Mar 31, 2024 | -24.57 Mn |
| Dec 31, 2023 | -17.22 Mn |
| Dec 31, 2023 | -17.22 Mn |